Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 751–789 of 789 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05945407	Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer	recruiting	N/A	57	Peking University People's HospitalOTHER	1	Jul 14, 2023	clinicaltrials
NCT05926726	GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma	recruiting	N/A	12	RenJi HospitalOTHER	1	Jul 3, 2023	clinicaltrials